Home / Resources / Discovery resources

药物发现

最新资源

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

精选资源

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Latest discovery blogs

All Discovery - Blog

Not just another ChatGPT: Why life sciences needs domain-specific AI

Mathematical modeling and the monkey king: Use of modeling for more efficient NHP study design

4 ways that mechanistic modeling accelerates bispecific (and multispecific) antibody drug development

Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndrome

药物发现平台开启科学数据访问之路

药物发现工具如何助力药物研发决策制定

在以下活动中与我们的专家会面

Discovery on Target 2026

September 28 - 2026 年 10 月 1 日 – Boston, MA + Virtual – Booth 516

Pistoia Alliance 2026 CSCS Conference

2026 年 9 月 29 - 30 日

BioTechX Europe 2026

2026 年 10 月 6 - 8 日

All Discovery resources

Pistoia Alliance 2026 CSCS Conference

Certara Products, Conference

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Certara Services, Drug Development, Model Informed Drug Development, Oncology, Pharmacometrics, Publication

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Cheminformatics, Blog

Toward Canonical HELM Representations for Sequence-Level Peptide Registration

Certara Products, Poster

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Certara Services, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

Discovery on Target 2026

Certara Products, Conference

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Certara Services, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Exploratory data analysis of a drug-biomarker-efficacy PD model

Certara University, Modeling and Simulation - PK/PD, Webinar

Cumyl‑PeGaClone: Emerging Synthetic Cannabinoids and the UK’s Evolving Legal Response

Certara Products, Cheminformatics, Blog

Why speed and scale matter in your discovery pipeline – A scalable compound registration

Cheminformatics, Blog

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Biologics, Modeling and Simulation, Modeling and Simulation - QSP, Publication

1
2
3
……
28
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software